Free Trial

Medexus Pharmaceuticals (MDP) Competitors

Medexus Pharmaceuticals logo
C$2.84 +0.06 (+2.16%)
As of 03:59 PM Eastern

MDP vs. ICC, CPH, RIV, LEAF, CRDL, RX, HLS, SUGR, TGOD, and NINE

Should you be buying Medexus Pharmaceuticals stock or one of its competitors? The main competitors of Medexus Pharmaceuticals include ICC Labs (ICC), Cipher Pharmaceuticals (CPH), RIV Capital (RIV), Leaf Mobile (LEAF), Cardiol Therapeutics (CRDL), BioSyent (RX), HLS Therapeutics (HLS), SugarBud Craft Growers (SUGR), Green Organic Dutchman (TGOD), and Delta 9 Cannabis (NINE). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Medexus Pharmaceuticals vs. Its Competitors

ICC Labs (CVE:ICC) and Medexus Pharmaceuticals (TSE:MDP) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends and valuation.

Medexus Pharmaceuticals has higher revenue and earnings than ICC Labs. Medexus Pharmaceuticals is trading at a lower price-to-earnings ratio than ICC Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICC LabsC$533.68K419.04C$2.35MC$0.0295.29
Medexus PharmaceuticalsC$100.25M0.63C$3.26MC$0.2113.58

Medexus Pharmaceuticals has a net margin of 3.25% compared to ICC Labs' net margin of 0.00%. Medexus Pharmaceuticals' return on equity of 11.07% beat ICC Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
ICC LabsN/A N/A N/A
Medexus Pharmaceuticals 3.25%11.07%4.89%

8.3% of Medexus Pharmaceuticals shares are owned by institutional investors. 9.1% of Medexus Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Medexus Pharmaceuticals had 1 more articles in the media than ICC Labs. MarketBeat recorded 1 mentions for Medexus Pharmaceuticals and 0 mentions for ICC Labs. ICC Labs' average media sentiment score of 0.00 equaled Medexus Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
ICC Labs Neutral
Medexus Pharmaceuticals Neutral

Medexus Pharmaceuticals has a consensus price target of C$5.49, indicating a potential upside of 93.22%. Given Medexus Pharmaceuticals' stronger consensus rating and higher probable upside, analysts plainly believe Medexus Pharmaceuticals is more favorable than ICC Labs.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICC Labs
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Medexus Pharmaceuticals
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
4 Strong Buy rating(s)
3.29

Summary

Medexus Pharmaceuticals beats ICC Labs on 13 of the 15 factors compared between the two stocks.

Get Medexus Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDP and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDP vs. The Competition

MetricMedexus PharmaceuticalsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$63.58MC$2.19BC$5.70BC$6.31B
Dividend YieldN/A2.92%4.69%6.72%
P/E Ratio13.584.1928.0775.38
Price / Sales0.63587.23448.571,359.95
Price / CashN/A10.3536.2283.29
Price / Book2.1011.028.664.89
Net IncomeC$3.26MC$21.15BC$3.25BC$301.20M
7 Day Performance1.07%1.40%4.20%1.18%
1 Month Performance-15.22%6.47%10.82%5.58%
1 Year Performance33.33%3.07%34.70%26.97%

Medexus Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDP
Medexus Pharmaceuticals
1.5389 of 5 stars
C$2.84
+2.2%
C$5.49
+93.2%
+29.3%C$63.58MC$100.25M13.5898Gap Up
ICC
ICC Labs
N/AC$1.62
-5.8%
N/A+0.0%C$223.64MC$533.68K95.29N/AGap Up
CPH
Cipher Pharmaceuticals
1.3671 of 5 stars
C$12.35
-0.6%
C$14.75
+19.4%
+40.6%C$221.72MC$19.03M13.645News Coverage
RIV
RIV Capital
N/AN/AN/AN/AC$213.65MC$11.33M-1.6312
LEAF
Leaf Mobile
N/AN/AN/AN/AC$198.42MC$83.74M58.86150
CRDL
Cardiol Therapeutics
N/AC$1.88
+12.6%
N/A-36.8%C$156MN/A-3.6920High Trading Volume
RX
BioSyent
N/AC$11.40
-0.4%
N/A+13.3%C$130.39MC$34.06M18.50N/ANews Coverage
Gap Up
HLS
HLS Therapeutics
N/AC$4.91
-1.6%
C$4.50
-8.4%
+52.5%C$109.24MC$40.13M-4.9291
SUGR
SugarBud Craft Growers
N/AC$13.40
-0.7%
N/A+62.4%C$91.39MC$575.64M16.1444High Trading Volume
TGOD
Green Organic Dutchman
N/AN/AN/AN/AC$89.95MC$31.37M-0.6541Gap Up
High Trading Volume
NINE
Delta 9 Cannabis
N/AC$1.03
+3.0%
N/A+0.0%C$89.36MC$12.87M19.07940Gap Up

Related Companies and Tools


This page (TSE:MDP) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners